English ticker view
NAMS
NEWAMSTERDAM PHARMA COMPANY
This page combines public comments, SEC 13F holdings, insider trades, and simple return calculations for one ticker. Use the original source links before making your own decision.
Current price
$36.15
Public comments
0
13F holding rows
45
Insider trade rows
5
Public comments
0
Ranked by current return where prices are available.
13F direction
24 / 15
New or increased positions vs reduced or sold positions.
Insider activity
0 buyers
Based on SEC Form 4 market purchase and sale rows.
Latest comments
Most recent public records
SEC 13F
Institution holding changes
JPMorgan Chase & Co.
sold out · May 13, 2026
+23.3%
Filing price $29.33 · Current $36.15
Brevan Howard Capital Management LP
new · May 15, 2026
+15.1%
Filing price $31.42 · Current $36.15
Janus Henderson Group PLC
unchanged · May 18, 2026
+13.0%
Filing price $31.985 · Current $36.15
Geode Capital Management, LLC
increased · May 15, 2026
+13.0%
Filing price $31.993 · Current $36.15
Duquesne Family Office LLC
unchanged · May 15, 2026
+12.9%
Filing price $32.0099 · Current $36.15
Northern Trust Corp
unchanged · May 14, 2026
+12.9%
Filing price $32.01 · Current $36.15
Envestnet Asset Management Inc
decreased · May 4, 2026
+12.9%
Filing price $32.01 · Current $36.15
Legal & General Group Plc
decreased · May 8, 2026
+12.9%
Filing price $32.01 · Current $36.15
Insider trades
SEC Form 4 summary
Market sells
1 owners
Rows
3
Estimated amount
$3,528,009.00
Average price $33.6001 · Latest Jun 22, 2026